<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04818580</url>
  </required_header>
  <id_info>
    <org_study_id>20-01803</org_study_id>
    <nct_id>NCT04818580</nct_id>
  </id_info>
  <brief_title>Progressive Tension Sutures in Gender Affirming Mastectomy</brief_title>
  <official_title>A Prospective Cohort Study Comparing the Effect of Progressive Tension Sutures and Drains to Drains Alone on Rates of Hematoma and Seroma in Gender Affirming Mastectomy for Transgender Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      50 patients seeking gender affirming mastectomy will be treated with different closure&#xD;
      techniques in each side of their chest - one side will receive progressive tension sutures&#xD;
      between pectoral fascia and the mastectomy flap, and the other side will not. Both sides will&#xD;
      have drains in the mastectomy site. Rates of hematoma, seroma, and other complications will&#xD;
      be compared between each chest side via standard statistical techniques for hypothesis&#xD;
      testing.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>A random number generator will be used. Subjects will be blinded as to which side of the chest has the sutures.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Total volume of Drain Fluid</measure>
    <time_frame>Visit 2, Day 7</time_frame>
    <description>Participants will record drain outputs each time they empty drains in the Postoperative Drain Output Record (mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total volume of Drain Fluid</measure>
    <time_frame>Visit 3, Day 14</time_frame>
    <description>Participants will record drain outputs each time they empty drains in the Postoperative Drain Output Record (mL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total volume of Drain Fluid</measure>
    <time_frame>Visit 4, Day 30</time_frame>
    <description>Participants will record drain outputs each time they empty drains in the Postoperative Drain Output Record (mL)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hematoma</condition>
  <condition>Seroma</condition>
  <arm_group>
    <arm_group_label>Right-Sided Progressive Tension Sutures</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Left-Sided Progressive Tension Sutures</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Progressive Tension Sutures</intervention_name>
    <description>In each patient, one side of the chest will receive progressive tension sutures inside the mastectomy pocket, from pectoral fascia to underside of mastectomy flap. 2-0 Vicryl about 15-20 sutures per chest. Both sides will receive bilateral drains (standard of care)</description>
    <arm_group_label>Left-Sided Progressive Tension Sutures</arm_group_label>
    <arm_group_label>Right-Sided Progressive Tension Sutures</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Being consulted for gender affirming mastectomy with the senior author (AH).&#xD;
&#xD;
          2. &gt;18 years of age at the time of enrollment.&#xD;
&#xD;
          3. Transgender or gender nonbinary gender identity.&#xD;
&#xD;
          4. All co-morbidities and all indications.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Age less than 18 years.&#xD;
&#xD;
          2. BMI &lt; 23.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Transgender men</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexes Hazen, MD FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Calahan</last_name>
    <phone>9294555826</phone>
    <email>Thomas.Calahan@nyulangone.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Calahan</last_name>
      <email>Thomas.Calahan@nyulangone.org</email>
    </contact>
    <investigator>
      <last_name>Alexes Hazen, MD FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ian Nolan, BM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Daar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2021</study_first_posted>
  <last_update_submitted>March 25, 2021</last_update_submitted>
  <last_update_submitted_qc>March 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mastectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematoma</mesh_term>
    <mesh_term>Seroma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.</ipd_time_frame>
    <ipd_access_criteria>The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to Thomas.Calahan@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

